>Pharming doesn't appear to have the cash for a clean buyout.<
I doubt that a buyout would be an all-cash transaction. Pharming presumably wants a listing on a U.S. stock market and GTC has that. Pharming would also want to make use of GTC’s tax losses in the U.S.
A way for Pharming to accomplish both of these objectives is a reverse merger in which GTC would be the surviving entity but Pharming’s shareholders would own more than half of the combined equity. GTC’s shareholders could still get a nice premium under such a transaction.
[Posted as a reply to: Msg 29087 by wjlknew] <<
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”